ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/06/26 | 4,241 | 4,275 | 4,208 | 4,228 | -31 | -0.7% | 241,800 |
2024/06/25 | 4,210 | 4,275 | 4,200 | 4,259 | +49 | +1.2% | 355,600 |
2024/06/24 | 4,117 | 4,237 | 4,100 | 4,210 | +85 | +2.1% | 416,900 |
2024/06/21 | 4,091 | 4,137 | 4,085 | 4,125 | +73 | +1.8% | 405,600 |
2024/06/20 | 4,074 | 4,108 | 4,043 | 4,052 | +5 | +0.1% | 269,900 |
2024/06/19 | 4,109 | 4,125 | 4,035 | 4,047 | -34 | -0.8% | 245,300 |
2024/06/18 | 4,075 | 4,111 | 4,055 | 4,081 | +18 | +0.4% | 257,700 |
2024/06/17 | 4,084 | 4,095 | 4,007 | 4,063 | +13 | +0.3% | 190,400 |
2024/06/14 | 3,977 | 4,067 | 3,975 | 4,050 | +3 | +0.1% | 343,800 |
2024/06/13 | 4,090 | 4,149 | 4,018 | 4,047 | +15 | +0.4% | 433,500 |
2024/06/12 | 4,050 | 4,050 | 3,978 | 4,032 | -15 | -0.4% | 263,400 |
2024/06/11 | 4,029 | 4,094 | 4,021 | 4,047 | +5 | +0.1% | 292,100 |
2024/06/10 | 3,987 | 4,042 | 3,976 | 4,042 | +80 | +2% | 288,600 |
2024/06/07 | 3,970 | 3,989 | 3,940 | 3,962 | +1 | ±0% | 192,900 |
2024/06/06 | 4,059 | 4,059 | 3,935 | 3,961 | -66 | -1.6% | 267,700 |
2024/06/05 | 4,002 | 4,084 | 3,996 | 4,027 | +25 | +0.6% | 374,100 |
2024/06/04 | 4,015 | 4,025 | 3,971 | 4,002 | -5 | -0.1% | 261,100 |
2024/06/03 | 3,960 | 4,051 | 3,959 | 4,007 | +57 | +1.4% | 345,900 |
2024/05/31 | 3,858 | 3,955 | 3,844 | 3,950 | +130 | +3.4% | 456,900 |
2024/05/30 | 3,784 | 3,833 | 3,740 | 3,820 | +51 | +1.4% | 387,700 |
2024/05/29 | 3,806 | 3,807 | 3,747 | 3,769 | -37 | -1% | 286,500 |
2024/05/28 | 3,816 | 3,829 | 3,775 | 3,806 | -55 | -1.4% | 308,100 |
2024/05/27 | 3,872 | 3,872 | 3,807 | 3,861 | -6 | -0.2% | 229,100 |
2024/05/24 | 3,868 | 3,886 | 3,816 | 3,867 | -35 | -0.9% | 354,000 |
2024/05/23 | 3,948 | 3,949 | 3,861 | 3,902 | +24 | +0.6% | 377,000 |
2024/05/22 | 3,900 | 3,911 | 3,851 | 3,878 | -51 | -1.3% | 421,800 |
2024/05/21 | 3,976 | 4,038 | 3,913 | 3,929 | -28 | -0.7% | 373,400 |
2024/05/20 | 3,965 | 4,022 | 3,943 | 3,957 | +10 | +0.3% | 396,700 |
2024/05/17 | 3,887 | 3,978 | 3,878 | 3,947 | +46 | +1.2% | 325,600 |
2024/05/16 | 3,885 | 3,931 | 3,850 | 3,901 | -50 | -1.3% | 511,400 |
2024/05/15 | 4,049 | 4,090 | 3,951 | 3,951 | -106 | -2.6% | 494,600 |
2024/05/14 | 4,071 | 4,118 | 4,023 | 4,057 | -14 | -0.3% | 678,200 |
2024/05/13 | 4,387 | 4,388 | 4,054 | 4,071 | -321 | -7.3% | 2,009,900 |
2024/05/10 | 4,392 | 4,392 | 4,383 | 4,392 | +700 | +19% | 1,121,000 |
2024/05/09 | 3,726 | 3,732 | 3,656 | 3,692 | -58 | -1.5% | 463,100 |
2024/05/08 | 3,701 | 3,772 | 3,685 | 3,750 | -7 | -0.2% | 348,000 |
2024/05/07 | 3,712 | 3,797 | 3,701 | 3,757 | +17 | +0.5% | 382,600 |
2024/05/02 | 3,819 | 3,825 | 3,721 | 3,740 | -45 | -1.2% | 243,600 |
2024/05/01 | 3,769 | 3,799 | 3,734 | 3,785 | -15 | -0.4% | 307,000 |
2024/04/30 | 3,799 | 3,824 | 3,771 | 3,800 | +45 | +1.2% | 299,900 |
2024/04/26 | 3,727 | 3,755 | 3,643 | 3,755 | +55 | +1.5% | 537,300 |
2024/04/25 | 3,745 | 3,758 | 3,691 | 3,700 | -59 | -1.6% | 466,300 |
2024/04/24 | 3,758 | 3,764 | 3,693 | 3,759 | -18 | -0.5% | 370,800 |
2024/04/23 | 3,731 | 3,812 | 3,730 | 3,777 | -17 | -0.4% | 377,500 |
2024/04/22 | 3,795 | 3,824 | 3,745 | 3,794 | +17 | +0.5% | 361,700 |
2024/04/19 | 3,814 | 3,814 | 3,663 | 3,777 | -73 | -1.9% | 606,700 |
2024/04/18 | 3,878 | 3,899 | 3,843 | 3,850 | -30 | -0.8% | 325,000 |
2024/04/17 | 3,935 | 3,946 | 3,833 | 3,880 | -31 | -0.8% | 414,700 |
2024/04/16 | 3,899 | 3,931 | 3,872 | 3,911 | -2 | -0.1% | 303,400 |
2024/04/15 | 3,938 | 3,965 | 3,865 | 3,913 | -47 | -1.2% | 324,800 |
101~
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 482,300円 | +22.6% | +68.1% | 2.82% | 12.85倍 | 1.24倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ロート | 274,500円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 166,400円 | 0.0% | +50.6% | 2.04% | 17.73倍 | 1.99倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
久光薬 | 428,400円 | +7.3% | -3.8% | 2.10% | 19.89倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 256,300円 | +56.7% | +357.2% | 0.00% | 23.73倍 | 5.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム